Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
暂无分享,去创建一个
J. Kim | J. Cheong | Minjong Lee | H. Cho | T. S. Lim | Seung-Up Kim | S. Kim | Ho Soo Chun
[1] Jae Hyun Kim,et al. 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association. , 2021, Diabetes & metabolism journal.
[2] A. Dhawan,et al. NAFLD to MAFLD in adults but the saga continues in children: an opportunity to advocate change.: Letter regarding "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement". , 2021, Journal of hepatology.
[3] V. Wong,et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study , 2020, The lancet. Gastroenterology & hepatology.
[4] Byung Jin Kim,et al. 2018 Guidelines for the Management of Dyslipidemia in Korea , 2019, The Korean journal of internal medicine.
[5] Ju Han Kim,et al. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension , 2019, Clinical Hypertension.
[6] J. Kang,et al. 2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea , 2019, Journal of obesity & metabolic syndrome.
[7] M. Allison,et al. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis , 2016, The American Journal of Gastroenterology.